It has been hypothesized that respiration defects caused by accumulation of pathogenic mitochondrial DNA (mtDNA) mutations and the resultant overproduction of reactive oxygen species (ROS) or lactates are responsible for aging and ageassociated disorders, including diabetes and tumor development. However, there is no direct evidence to prove the involvement of mtDNA mutations in these processes, because it is difficult to exclude the possible involvement of nuclear DNA mutations.
INTRODUCTION
Pathogenic mtDNA mutations that induce significant mitochondrial respiration defects are responsible for mitochondrial diseases (1, 2) and could also be involved in aging and ageassociated disorders, including tumor development (1) (2) (3) (4) (5) . On the other hand, mitochondrial respiration defects caused by nuclear DNA mutations and the resultant enhanced glycolysis under normoxic conditions, i.e., the Warburg effect, are proposed to be involved in tumor development (6) (7) (8) (9) . Because pathogenic mtDNA mutations also induce mitochondrial 3 respiration defects and upregulation of aerobic glycolysis, accumulation of these mtDNA mutations with age could also be responsible for tumor development. In addition, it is possible that mtDNA mutations regulate tumor development as a consequence of overproduction of reactive oxygen species (ROS) and the resultant induction of genetic instability (1, 2, 10) . In fact, somatic mtDNA mutations are preferentially accumulated in human tumor cells (11) (12) (13) , and a germline mtDNA mutation (A8344G) in the tRNA Lys gene has been found in lipomas (benign adipose tissue tumors) (14) . However, there is as yet no direct evidence for the contribution of mtDNA mutations to aging and tumor development, because of the difficulty of excluding the possible contribution of nuclear DNA mutations, including copy number variants (CNVs), to these processes (2, 15) .
Our previous study (16) resolved this issue by using complete mtDNA exchange technology between mouse normal and tumor cells, and we showed that exogenously introduced mtDNA does not affect tumorigenicity. In contrast, our recent study (17) performed exchange of mtDNA between poorly and highly metastatic mouse tumor cells, providing convincing evidence that the somatic mtDNA mutation G13997A in the ND6 gene, which encodes one of the subunits of respiration complex I (NADH dehydrogenase), reversibly controls the development of highly metastatic potential in tumor cells. Moreover, the induction of metastasis is due to overproduction of ROS (17) but not to overproduction of lactates (18) . However, these studies have not answered the questions of whether the mutated mtDNA actually controls metastatic phenotypes in living mice and whether it also controls aging and age-associated disorders, including tumor development. Because it is not possible to examine these questions as far as the mutated mtDNA is confined in tumor cells, we performed intercellular transfer of G13997A mtDNA from highly metastatic tumor cells into mouse embryonic stem cells, and generated transmitochondrial mito-mice possessing only G13997A mtDNA (19) . M ), 26.0 (B6 mice), and 26.6 months (mito-miceCOI M ); these differences were not significant (Fig. 2B) . The slightly shorter median survival times of mito-miceND6 M compared with those of B6 mice ( Fig. 2A) were therefore at least partly due to the higher frequency of abnormal-tissue formation in aged mito-miceND6 M than in age-matched B6 mice (Table 1) .
Histological analyses of abnormal tissues revealed that all were hematopoietic neoplasms and were positive for the pan-leukocyte marker CD45 (Table 1 and Fig. 3B ). As no leukemic cells were observed in the peripheral blood (Fig. 3A) , these hematological neoplasms may have consisted of lymphoma cells. Most tumors were of B-cell origin, expressing the B-cell marker B220 (CD45R) (Fig. 3B) ; they were either follicular lymphoma or diffuse large B-cell lymphoma arising in the spleen, liver, or lung (Table 1) .
One aged mito-miceND6 M male and one aged B6 male developed T-cell lymphoma, staining positive for the T-cell marker CD3 ( (Table 1) . Thus, the tumor-inducing effect of G13997A mtDNA might be restricted to lymphoma formation, and it might therefore be difficult to examine the effects of G13997 mtDNA on metastatic potential in mito- (Table S1 ). By culturing these seven MEF lines using the 3T3 protocol (25, 26 ; see Methods), we isolated six (Table S1 ). The average numbers of cell divisions for the MEF lines to lose their finite lifespan were 7.9 for MEFB6 and 11.0 for MEFND6 M (Fig. 4A) , suggesting that at least three additional cell divisions were required for immortality in MEFND6 M with G13997A mtDNA. Therefore, G13997A mtDNA does not enhance, but instead slightly suppresses, immortalization in All of them rapidly formed tumor masses (Fig. 4C ), suggesting that they were fibrosarcoma lines expressing tumorigenicity. The lines were named FSB6-II, FSB6-III, FSND6 M -I, and FSND6 M -III (Table S1 ). FSB6-II and FSB6-III were confirmed to possess wild-type (B6) mtDNA, and FSND6 M -I and FSND6 M -III possessed G13997A mtDNA (Fig. 4D) .
We then examined the metastatic potential of the fibrosarcoma lines by inoculating them intravenously into B6 mice and counting nodule numbers in the lung. This malignant tumor phenotype was exclusively enhanced in the fibrosarcoma cell lines FSND6 M -I and -III ( Fig.   4E ), which carried G13997A mtDNA (Fig. 4D) , even though their primary tumor growth was slower than that of FSB6-II and -III (Fig. 4C) , which had B6 mtDNA (Fig. 4D) .
Therefore, G13997A mtDNA did not enhance immortalization and transformation of MEFs, but it enhanced the malignant progression of spontaneously-transformed MEFs to acquire high metastatic potential.
Discussion
Here, we used aged mito-miceND6 M with pathogenic G13997A mtDNA to examine conventional mitochondrial theory (1-5) proposing that respiration defects caused by pathogenic mtDNA mutations and the resultant ROS or lactate overproduction are responsible for aging and age-associated disorders. As controls we used age-matched B6 mice with normal mtDNA and mito-miceCOI M mice with pathogenic T6589C mtDNA (21), which induces respiration defects and the resultant lactate overproduction but not ROS overproduction (17) . All of the mice used in this study shared the B6 nuclear DNA background, thus excluding the possible involvement of nuclear genetic variations in the 10 phenotypes exclusively developed in mito-miceND6 M . The results showed that neither G13997A mtDNA nor T6589C mtDNA enhanced aging, but that G13997A mtDNA induced B-lymphoma formation and glucose intolerance, whereas T6589C mtDNA did not.
Therefore, this study provides convincing evidence that some pathogenic mtDNA mutations, such as the G13997A mutation, regulate age-associated disorders, including Blymphoma development and diabetes, in living mice. Moreover, G13997A mtDNA appeared to play various roles in the multiple steps required for MEF transformation. For example, G13997A mtDNA slightly suppressed immortalization of MEFs to loose their finite lifespan (Fig. 4A) , and it did not induce transformation of immortalized MEFs to acquire tumorigenicity (Fig. 4B) . However, it did induce malignant progression of the transformed MEFs to express high metastatic potential (Fig. 4E) . These results are consistent with our previous observations (17): using an in vitro culture system we previously showed that the G13997A mutation induced malignant progression of lung carcinoma cells to acquire high metastatic potential, but it did not induce transformation of immortalized NIH3T3 cells to acquire tumorigenicity (17) . Therefore, our finding here that the mutation induced frequent B-lymphoma development in mito-miceND6 M (Table 1) was unexpected.
The question that then arises is why were there only hematological malignancies (Table 1) despite the fact that respiration defects affected all of the tissues examined (Fig. 1A) . One answer to this tissue-specific tumor development is that the nuclear genetic background of the B6 mice used in this study made them prone to B-lymphoma formation but not to other tumors during their lifespans (Table 1 ). This idea can be examined by generating mitomiceND6 M carrying G13997A mtDNA but in a nuclear genetic background derived from another wild-type mouse strain that preferentially develops tumors other than B-lymphoma.
It has been proposed that nuclear genetic variations among wild-type mouse strains affect 11 the tumor formation spectrum (27) (28) (29) (30) , particularly when genetic manipulations are performed to induce tumor development (29, 30) . Thus the generation of new mitomiceND6 M would be effective for examining the issue of whether G13997A mtDNA enhances the development of different tumors in different nuclear genetic backgrounds, or whether it specifically enhances B-lymphoma development irrespective of whether the nuclear genetic background is derived from B6 or not.
Another question is the nature of the mechanism of B-lymphoma development in mitomiceND6 M . Analysis of CNVs showed partial gains of chromosomes 3 and 11 in a spleen with B-lymphoma from a mito-mouseND6 M (Fig. S3) . Thus, one possible mechanism could be chromosomal instability caused by G13997A mtDNA-mediated overproduction of ROS.
It has been proposed that oxidative stress induces various types of cellular damage, leading to chromosome instability that can result in tumor development (10) . Moreover, Blymphomas can be frequently induced as a consequence of chromosome translocation (31) .
Precise chromosome analysis may therefore reveal the mechanism of frequent B-lymphoma formation in mito-miceND6 M .
With respect to the aging of mito-miceND6 M , the G13997A mutation does not solely enhance aging or regulate premature aging phenotypes, which have been reported in mtDNA mutator mice possessing nuclear-coded mtDNA polymerase with a defective proofreading function and expressing the resultant mitochondrial respiration defects but not ROS overproduction (32) (33) (34) . Absence of the premature aging phenotypes in mitomiceND6 M is not unexpected, because there is no evidence that patients with mitochondrial diseases due to pathogenic mtDNA mutations develop generalized premature aging.
Therefore, the introduction of different nuclear genetic backgrounds or nuclear DNA 12 variations into mito-miceND6 M may be required to trigger the onset of their premature aging phenotypes.
Our results also suggested that the glucose intolerance observed exclusively in aged mitomiceND6 M (Fig. 1D) resulted from ROS overproduction. This idea was confirmed by the observation that NAC administration suppressed glucose intolerance (Fig. S2) . Continuous NAC administration could therefore be an effective therapy for improving ROS-mediated diabetic phenotypes. Because it has been proposed that ROS negatively controls insulin secretion from pancreatic β cells or glucose incorporation into insulin-targeted organs in humans (35) , mito-miceND6 M would be effective models for precise investigation of the mechanisms of ROS-mediated diabetes. On the other hand, a reduction in ATP content caused by mitochondrial respiration defects in pancreatic β cells has also been proposed to suppress their insulin secretion and could thus be responsible for inducing mitochondrial diabetes (36) . In fact, patients with mitochondrial diseases who carry an A3243G mtDNA mutation in the mitochondrial tRNA Leu(UUR) gene frequently express diabetic phenotypes (1, 35, 37). However, other pathogenic mtDNA mutations are not necessarily correlated with these phenotypes (37). Our mito-miceCOI M did not show glucose intolerance (Fig. 1D ),
indicating that respiration defects do not always induce diabetic phenotypes. Other mitomice carrying a pathogenic mutation in the mitochondrial tRNA Leu(UUR) gene will therefore have to be generated to resolve this controversy over the pathogenesis of mitochondrial diabetes.
Materials and Methods
Mice. Inbred B6 mice generated by sibling mating more than 40 times were obtained from CLEA Japan. Mito-miceND6 M (19) and mito-miceCOI M (21) were generated in our are located in the mitochondrial inner membrane. The activity of these enzymes was assayed as described previously (11) . Briefly, to estimate complex I + III activity, NADH and cytochrome c (oxidized form) were used as substrates and the reduction of cytochrome c was monitored by measuring absorbance at a wavelength of 550 nm. To estimate complex II + III activity, sodium succinate and cytochrome c (oxidized form) were used as substrates, and the reduction of cytochrome c was monitored as described above. 
Measurement of ROS Production in

Analysis of CNVs.
Copy number variations in nuclear DNA were examined by array CGH (comparative genomic hybridization) using a 4×44k whole-genome array (Agilent Technologies G4426B#15028). DNA (1 µg) derived from each male mouse spleen was used. A dye-swap experiment was conducted to confirm the results. The protocol for DNA digestion, labeling, purification, and hybridization to the arrays followed the manufacturers' instructions (Agilent Technologies).
Isolation of Immortal 3T3 Cells from MEFs. MEFs in a 6-cm culture dish at a density of 3×10 5 cells per dish were cultured by using the 3T3 protocol reported previously (25, 26) .
Briefly, 3 days after the cells had been plated at 3×10 5 cells per dish, we trypsinized them, counted the total cell numbers, and then replated 3×10 5 cells into 6-cm dishes. These processes were repeated until immortalized cells appeared.
Genotyping of mtDNAs.
Total cellular DNA (0.2 mg) extracted from cultured cells was used as a template. To detect the G13997A mutation, a 147-bp fragment containing the 13997 site was amplified by using PCR. The nucleotide sequences from nucleotide positions 13963 to 13996 (5′-CCCACTAACAATTAAACCTAAACCTCCATActTA-3′;
small letters indicate the mismatch site) and nucleotide positions 14109 to 14076 (5′-TTCATGTCATTGGTCGCAGTTGAATGCTGTGTAG-3′) were used as oligonucleotide primers. Combination of the PCR-generated mutation with the G13997A mutation created a restriction site for Afl II and generated 114-bp and 33-bp fragments on Afl II digestion.
Restriction fragments were separated by electrophoresis on 3% agarose gels containing ethidium bromide (0.1 mg/ml).
Assays of Metastatic Potential and Tumorigenicity.
To test for experimental metastatic potential, cells (5×10 5 /100 µl PBS) were injected into the tail vein of 6-week-old male B6 mice (CLEA Japan). The mice were euthanized 23 days later, and their lungs were removed. The lungs were fixed in Bouin's solution and parietal nodules were counted. To assess tumorigenicity, growing cells (5×10 6 cells) suspended in 100 µl PBS were injected
